Abeona Therapeutics Inc (NASDAQ:ABEO) shares, rose in value on Friday, March 28, with the stock price down by -1.39% to the previous day’s close as strong demand from buyers drove the stock to $4.97.
Actively observing the price movement in the last trading, the stock closed the session at $5.04, falling within a range of $4.85 and $5.1399. The value of beta (5-year monthly) was 1.782. Referring to stock’s 52-week performance, its high was $8.45, and the low was $3.05. On the whole, ABEO has fluctuated by -3.31% over the past month.
With the market capitalization of Abeona Therapeutics Inc currently standing at about $241.21 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-19.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ABEO’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ABEO currently trading nearly -4.06% and -8.00% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.59, while the 7-day volatility ratio is showing 4.05% which for the 30-day chart, stands at 5.34%. Furthermore, Abeona Therapeutics Inc (ABEO)’s beta value is 1.69, and its average true range (ATR) is 0.26.
A comparison of Abeona Therapeutics Inc (ABEO) with its peers suggests the former has fared considerably weaker in the market. ABEO showed an intraday change of -1.39% in last session, and over the past year, it shrunk by -32.47%%.
Data on historical trading for Abeona Therapeutics Inc (NASDAQ:ABEO) indicates that the trading volumes over the past 10 days have averaged 0.5 and over the past 3 months, they’ve averaged 333.17K. According to company’s latest data on outstanding shares, there are 45.64 million shares outstanding.
Nearly 11.70% of Abeona Therapeutics Inc’s shares belong to company insiders and institutional investors own 64.23% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.39 million shares as on 2025-03-14, resulting in a short ratio of 7.19. According to the data, the short interest in Abeona Therapeutics Inc (ABEO) stood at 516.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 2.47 million. The stock has fallen by -10.77% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ABEO stock heading into the next quarter.
